Univo Pharmaceuticals (XTAE:UNVO-M) Accounts Payable & Accrued Expense : ₪13.45 Mil (As of Jun. 2022)

View and export this data going back to 2011. Start your Free Trial

What is Univo Pharmaceuticals Accounts Payable & Accrued Expense?

Univo Pharmaceuticals's quarterly accounts payable & accrued expense increased from Dec. 2021 (₪12.96 Mil) to Mar. 2022 (₪14.16 Mil) but then declined from Mar. 2022 (₪14.16 Mil) to Jun. 2022 (₪13.45 Mil).

Univo Pharmaceuticals's annual accounts payable & accrued expense increased from Dec. 2019 (₪1.31 Mil) to Dec. 2020 (₪5.97 Mil) and increased from Dec. 2020 (₪5.97 Mil) to Dec. 2021 (₪12.96 Mil).

Univo Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Univo Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Univo Pharmaceuticals Accounts Payable & Accrued Expense Chart

Univo Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.32

1.31

5.97

12.96

Univo Pharmaceuticals Quarterly Data
	Dec14	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial													12.15	14.68	12.96	14.16	13.45

Univo Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Univo Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Univo Pharmaceuticals Ltd (XTAE:UNVO-M) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Harshar 20, Ashkelon, ISR, 7878329

Website

https://www.univopharma.com

Univo Pharmaceuticals Ltd is engaged in designing & developing drugs for the treatment of brain disorders. The company provides cannabis-based products for distribution and export to the international markets.

Univo Pharmaceuticals Headlines

No Headlines